If you have been an investor in one of the many cannabis-related stocks that have sprung up on the boards over the past several years, you’ve probably been stymied when it came to taking out a margin loan against them. Because of the still-existing federal treatment of marijuana as a drug, major banks and brokerages have been unwilling or unable to provide the normal lending facilities against these stocks that many investors have sought.
Now at A. B. Nicholas, the leader in innovative personal loans using stock portfolios as collateral, we are happy to announce that for cannabis stocks that meet our basic, standard lending criteria, we can use portfolios of such stocks for our market-leading LeverageLine stock loan program.
Provided that the stock trades at $5 a share or higher consistently, and has an average trailing four week volume of at least 250,000 shares per day trading, we can provide a line of credit at up to 85% on the value of your cannabis portfolio. Highest LTV is available for multistock portfolios; lowest LTV (70%) for single stock portfolios in most cases.
Our rates are unmatched in the industry, as we have arranged special lending facilities at three major U. S. institutions. And if your stocks currently reside at TD Ameritrade or Schwab, you can leave them right there. No need to transfer the portfolio to one of the major 3rd-party licensed public bank/brokerages with which we have partnered if your stocks. are at one of these institutions.
Get a quote today. It’s fast, secure, and easy. And all of our loan quotes are equivalant of pre-approved financing if you have submitted a recent valid brokerage statement.
So what are you waiting for? Now the best stock loan in the business is available for those who’ve chosen to invest in cannabis securities. We’re ready to help.